Common Repository (User Interface and API) is now extended to include the following types of submissions related to procedures for Human Medicinal Products: Signal Detection, PASS 107 NAPs, Work share NAPs and Ancillary products for new submissions from the 8th of March 2018 onwards. This will be followed by a transitional period of 6-9 months, [...]

As of 15 February 2018 version 1.22 of the four electronic Application Forms (eAFs) are mandatory. Older versions of the forms will no longer be supported.

The CHMP Pharmacovigilance Working Party (PhVWP) was responsible for evaluating and monitoring safety issues for human medicines until 2012; it was then replaced by the Pharmacovigilance Risk Assessment Committee (PRAC) with the entry into force of Directive 2010/84/EU. PhVWP recommendation

PSUR Summaries of Assessment Reports after PSUR Work sharing CMDh lists in alphabetical order according to substance, summaries of evaluation reports. The list is updated once a PSUR procedure has been concluded. CMDh - PSUR Work sharing procedure

Please find an updated version of the PLM Portal eAF Guide to Registration here.

An updated version of the Harmonised Technical Guidance for ASMF Submissions in eCTD format and the related Release notes are now available here.

Ramipril/bisoprolol Date of publication: 28/07/2023

An updated version 1.26.0.0 of the veterinary variation eAFs is available starting with 24 July 2023.

Version 1.22 of the electronic Application Forms (eAFs) will become available on 15 December 2017.The release v1.22 will provide integration with OMS from SPOR (Organisational/address data), usability improvements and technical defect fixes. User Acceptance Testing (UAT) is planned to support the release of this next version of the forms. testing by Industry and NCAs will [...]

Imovax Polio SK/W/0002/pdWS/001 End of Procedure: 18/04/2011 Date of Publication: 28/09/2012 HR/W/0001/pdWS/001 End of procedure: 06/06/2023 Date of publication: 28/07/2023